It is well documented that responses to growth factor treat-
Introduction
Nonviral gene therapy has several advantages over viral gene therapy. Nonviral delivery systems typically result in robust, prompt and transient localized gene expression without triggering confounding immunological responses or tachyphylaxia. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] To approach the clinical use of nonviral gene therapy, better understanding and determination of mechanisms are necessary. We have determined optimal liposome/DNA ratios, biodistribution and feasibility of nonviral liposomal cDNA complexes injections into the skin. [9] [10] [11] [12] We have shown that after the injection of liposomal cDNA complexes, the transferred gene was transcribed into mRNA and translated into the protein. 12 The translated protein was not only shown to be physiologically active, but also to be more potent when the same factor administered as a recombinant protein at a 100-fold higher concentration. 9 As it is physiologically well documented that effects and efficacy of a protein administered to target tissues are dose-dependent, we asked whether liposomal nonviral gene therapy displays the same dose-dependent mechanisms independent of the genes transferred. To test this hypothesis, we characterized growth factor gene transfer at concentrations below and above an optimal concentration determined for IGF-I cDNA and also carried out similar dose-response measurements using a CMVdriven KGF cDNA vector suspected of acting via a different mechanism.
Keratinocyte growth factor (KGF), a 26-28 kDa protein, is a member of the fibroblast growth factor family with great potency to improve wound healing. [16] [17] [18] KGF is mainly synthesized in various types of mesenchymal cells, such as fibroblasts, microvascular endothelial cells and smooth muscle cells. 19, 20 In vitro studies demonstrated that KGF exerts its effects primarily in a paracrine fashion and is essential for skin morphogenesis. 17, 21 In addition, it has been shown to stimulate proliferation and to exert an anti-apoptotic effect on epithelial cells, while it stimulates epithelial cell differentiation and controls the proliferative-differentiative program from basal to suprabasal skin cells with great therapeutic potential for improving the wound repair process. 16, 17, 22, 23 Insulin-like growth factor-I (IGF-I) a 7.7-kDa single chain polypeptide of 70 amino acids with sequence homology to proinsulin, has been shown to improve metabolic rate, gut mucosal function and protein loss after a burn injury. [24] [25] [26] [27] In the circulatory system 95-99% of IGF-I is bound and transported with one of its six binding proteins. 25 IGF-I is known to mediate the actions of growth hormone in the hypermetabolic state by attenuating lean body mass loss, improving the immune response, attenuating the acute phase response, and by enhancing wound healing. 9, [28] [29] [30] Fibroblasts and keratinocytes have IGF-I receptors which probably mediate IGF-I stimulation of mitogenicity and proliferative activity. 31 In experimental and clinical studies the great potential of IGF-I to improve wound healing has been shown. 31, 32 By using these two different growth factors, we determined whether nonviral liposomal cDNA gene transfer is dependent on the concentration of the cDNA administered and underlies dose dependency, in order to improve our understanding of the molecular mechanisms of nonviral liposomal gene therapy. In order to determine the effects we chose the burn-wound healing model, because it is easily accessible, standardized and welldefined. To evaluate the efficacy of gene transfer to the skin, we chose to determine wound healing parameters, such as re-epithelization, morphologic parameters, collagen structure, protein concentration, skin proliferation, skin apoptosis and neo-angiogenesis, that are well characterized to be crucial in the complex cascade of dermal and epidermal regeneration.
Results

Transfection
Confirming previous experiments, the fine granular bluegreen reaction product of the ␤-galactosidase reaction was predominantly present in the granulation tissue, composed of spindle-shaped myofibroblasts, macrophages and growing small blood vessels underlying the wound. The cells consistently staining for ␤-galactosidase were myofibroblasts, endothelial cells, macrophages located in the areas of inflammation and indicating preferential transfection of cells with higher proliferation rates. Although most staining for ␤-galactosidase was in the cytoplasm, there were reaction products outside the cell boundaries, possibly due to enzymes released by dead cells or the simple diffusion of reaction products ( Figure 1 ). The LacZ transfection provided positive evidence for liposomal gene transfer since ␤-galactosidase is not present in mammalian tissues, thus the observation of ␤-galactosidase activity could not be due to upregulation of the endogenous enzyme.
KGF skin concentration
Immunohistochemistry using antibodies against KGF indicated KGF expression in the same area in which we found a positive reaction for transfection, indicated by the histological examinations for ␤-galactosidase. KGF expression was dose-dependent, with the highest expression being observed in animals treated with liposome:DNA complexes with 2.2 g of DNA, P Ͻ 0.05 ( Figure 2 ). 
IGF-I skin concentration
IGF-I protein expression in the skin after IGF-I gene transfer is shown in Figure 3 . Animals receiving the IGF-I cDNA construct at a dose of 2.2 g had the highest IGF-I protein expression compared with the 0.22 g and 22.2 g injection dose or to vehicle, P Ͻ 0.05 ( Figure 3) . The group treated with 22.2 g of IGF-I cDNA construct also displayed a significant increase in local IGF-I protein concentration compared to vehicle, P Ͻ 0.05. This result would suggest that while dose-response curves were similar for both KGF and IGF-I gene transfer, there were minor differences which may reflect differences in CMVdriven constructs or interactions with endogenous growth factor levels. 
Re-epithelization
Re-epithelization, determined by planimetry, was significantly increased in rats receiving the liposomal KGF cDNA complex at all three doses when compared with rats receiving the liposomes containing the cDNA for ␤-galactosidase, P Ͻ 0.05 ( Figure 4a ). Rats receiving liposomal IGF-I cDNA complexes at a dose of 2.2 g and 22.2 g demonstrated accelerated re-epithelization when compared with rats receiving the vehicle with the LacZ cDNA, (P Ͻ 0.05, Figure 4a ). However, the highest percentage of re-epithelization was found in animals receiving 2.2 g of either KGF cDNA or IGF-I cDNA complexes, which was significantly different from all other values (P Ͻ 0.001).
Histological examinations of re-epithelization revealed similar results compared with planimetry. Rats treated with the KGF cDNA gene complex at a dose of 2.2 g showed a linear re-epithelization of 390 ± 25 m 5 weeks after burn. In comparison, rats treated with the IGF-I cDNA gene complex at a dose of 2.2 g had a linear reepithelization of 380 ± 20 m 5 weeks after burn. Linear re-epithelization in these two groups was significantly increased when compared with KGF and IGF-I at doses of 0.22 g and 22.2 g and the vehicle with the LacZ gene, P Ͻ 0.001 ( Figure 4b ). Both area and linear re-epithelization is shown to reflect a dose-dependent physiological response.
Collagen morphology and deposition KGF cDNA and IGF-I cDNA gene transfer improved quality and quantity of deposited collagen in a dosedependent manner. In rats receiving the KGF cDNA at a dose of 2.2 g collagen formation was 2.2 ± 0.1, significantly higher than the collagen formation in rats receiving vehicle 1.8 ± 0.1, P Ͻ 0.05 (Table 1) . Similarly, staining intensity of collagen deposition was significantly higher in rats treated with KGF cDNA 2.9 ± 0.2 when compared with vehicle 2.1 ± 0.1, P Ͻ 0.05 (Table 1) . We also found that KGF cDNA at 2.2 g significantly increased the length and the area of the collagen pannus when compared with vehicle, P Ͻ 0.05 (Table 1) . KGF cDNA given in a dose of 0.22 g and 22.2 g did not show any positive effects in improving collagen deposition when compared with vehicle (Table 1) .
IGF-I cDNA transfer significantly improved collagen bundle morphology and density at a dose of 2.2 g when compared with vehicle, 0.22 g and 22.2 g, P Ͻ 0.05 Table 1 Collagen bundle morphology, staining intensity, collagen pannus length, depth and area and its dose dependency ( Table 1 ). The length of the collagen pannus was significantly longer in the 2.2 g and 22.2 g IGF-I cDNA group when compared with vehicle and 0.22 g, P Ͻ 0.05. However, the area of the pannus only increased for the 2.2 g IGF-I cDNA-treated group, P Ͻ 0.05 (Table 1) .
Skin cell proliferation and apoptosis KGF cDNA gene transfer at a dose of 2.2 g significantly increased basal cell proliferation when compared with 0.22 g and vehicle, P Ͻ 0.05 (Table 2) . Similarly, 2.2 g IGF-I cDNA gene transfer increased basal cell proliferation when compared with 0.22 g, 22.2 g and vehicle, P Ͻ 0.05 (Table 2) . Apoptosis was significantly decreased in the KGF cDNA 2.2 g and IGF-I cDNA 2.2 g group when compared within treatment groups, P Ͻ 0.05. Thus, both groups had an improved net balance calculated as proliferation divided by apoptosis, when compared within treatment groups at different concentrations and liposomes alone, P Ͻ 0.05.
Neo-angiogenesis
Neo-angiogenesis is defined by newly formed blood vessels in the granulation tissue. Rats receiving the cDNA for either KGF or IGF-I at a concentration of 2.2 g exhibited the highest concentration of newly formed blood vessels in the granulation tissue, when compared within groups and with vehicle, P Ͻ 0.05 ( Figure 5 ).
Discussion
The present study was designed to assess the general efficacy of nonviral liposomal gene transfer to the skin. We showed that efficacy of nonviral cDNA gene transfer is dose-dependent and displays similar features irrespec- tive of the growth factor gene transferred. Both growth factor cDNA constructs tested were most effective at a concentration of 2.2 g cDNA and enhanced and accelerated dermal and epidermal regeneration after wounding. Most striking in the present study was the expression and physiological presence of the multifactorial dose dependency. Protein expression of the transferred gene and the resulting physiological response had a peak at a concentration of 2.2 g transferred cDNA. The effects could not be further augmented by using higher concentrations. In contrast, 22.2 g transferred cDNA had a mostly negative effect on protein expression and physiological responses. The concentration of 0.22 g cDNA construct proved to be too small to yield efficient gene transfer. That the dose-response is not limited to solely one growth factor was also shown here, since the two different growth factor cDNA constructs gave the same pattern of expression as a function of concentration.
The skin represents a good model to study mechanisms of nonviral gene transfer because of its accessibility and the ease of monitoring the modified area. 33 It is likely that there is a dose-dependent response after cDNA transfers in other organs as well as skin. The finding of such a dose-response has clinical relevance for oncology, vascular and bronchial gene therapy, in all of which liposomes are used as a delivery system. 34 When liposomes were discovered by Bangham, their in vivo utility was largely met with skepticism. 35, 36 Although the nonviral nature of liposomes and their in vivo stability are attractive, their use has been limited to in vitro applications due to the very low in vivo transfection efficiencies. 37 Modification of the standard liposomal structure to a cationic structure improved the efficacy of liposomal constructs. 37, 38 The change from multivalent cationic lipids to monovalent cationic lipids further improved transfection rates. 39 The use of a cytomegalovirus promoter in the cDNA constructs used for gene transfer, also increased the efficacy and transgenic expression levels compared with those previously achieved with adenovirus constructs. 37, 38 As a vector for gene therapy, liposomes have become attractive due to their nonviral composition, stability, ability to interact with the cell membrane and protect the cDNA from degradation. 37 DNA-liposome complexes bind to the negatively charged cell surface due to presence of excess positive charges in the complex. The nature of nonspecific interactions results in prompt and efficient transfection of many cell types. The flexibility in the design of cationic lipid structures and the variety of methods used in the liposomal preparation could broaden their scope for therapeutic use. [39] [40] [41] Cationic liposomal complexes seem suitable for use after thermal injury, because liposomes attenuate proinflammatory hypermetabolism and acute phase response present after trauma due to stabilization of cell membranes and enhancement of nutrient uptake. 42 Liposomes can be applied by either topical administration or by direct injection of liposomal gene constructs. 9, 12, 14, 33 Alexander and Akhurst 33 demonstrated that topical application of liposomal constructs containing the LacZ gene in shaved 4-week-old mice resulted in transfection and expression in the epidermis, dermis and hair follicle. Topical administration of liposomal complexes, however, has been speculated not to be as effective as injection in cell transfection and expression. 11, 15 This is due to the stratum corneum, which is the protective layer of the epidermis. Thus, injecting the liposomal gene complexes improves transfection of dermal and epidermal cells. After normal skin transfection expression is predominantly in keratinocytes with lower levels of expression in dermal cells. 43 Transfection, however, has been shown to be transient under these conditions. 11, 15, 43 The reason for transient transfection and expression is due to degraGene Therapy dation and loss of the DNA constructs and a lack of stable gene transfection into stem cells, eg keratinocyte stem cells. 15 Only a few studies have been performed to characterize nonviral liposomal gene transfer of growth factors to skin. 9, 12, 44 Sun et al 44 administered a FGF topically plus subcutaneous injection on a daily basis in diabetic mice with incisional wounds. The authors found that transfection with aFGF increased wound breaking strength and improved wound quality when compared with controls. We studied the effects IGF-I on wound healing by injecting IGF-I cDNA constructs into the skin. 9, 12 We showed that after the injection of liposomal cDNA complexes, transfection occurred in myofibroblasts, endothelial cells and macrophages, including multinucleate giant cells. All are known to be proliferative. The transferred gene was transcribed into mRNA and translated into IGF-I protein. The translated protein was not only shown to be physiologically active, but also to be more potent then the same factor administered as a recombinant protein in a 100-fold higher concentration. 9, 12 Based on these observations, we concluded that nonviral liposomal gene transfer to enhance wound healing is an approach that may be more effective than recombinant protein application. We did not determine the efficacy of the proteins compared with the gene constructs in the present study, however, both growth factor cDNA constructs used accelerated linear and area re-epithelization, collagen formation and morphology and dermal and epidermal regeneration.
The most important function of the skin is to serve as a protective barrier against external influences, such as the environment. 45 The loss of dermal integrity may lead to loss of fluid, energy and increased permeability accompanied by an increased risk of bacterial translocation and thus the development of infection or even sepsis. Wound healing is critical for morbidity and mortality in acute and chronic wounds. We suggest that nonviral liposomal cDNA gene transfer to the skin is a unique approach that improves morbidity and mortality after injury. Therapy success and efficacy was shown in the present study to be dose-dependent.
Materials and methods
Thirty-five adult male Sprague-Dawley rats (350-375 g) were placed in wire-bottom cages housed in a temperature-controlled room with a 12-h light-dark cycle. Rats were acclimatized to their environment for 7 days before being entered into the blinded study. All animals received similar amounts of a liquid diet of Sustacal (Mead Johnson Nutritionals, Evansville, IN, USA) and water ad libitum throughout the study. Both groups of rats were pair-fed according to the caloric intake. The feeding protocol was as follows: 25 calories on the day of burn, 51 calories on the first postburn day, 76 calories on the second, and 101 calories from the third day postburn onwards. Nutritional intake was the same in all groups. Each rat received a 60% total body surface area (TBSA) full-thickness scald burn under general anesthesia (pentobarbital 50 mg/kg body weight) and analgesia (buprenorphin 1 mg/kg body weight) following a modified procedure as previously described. 46 Briefly, rats were anesthetized, shaved, placed in a mole and received a 60% TBSA scald burn (99 o C hot water; water contact 10 s to the back and 1.5 s to the belly). After the thermal injury, rats were immediately resuscitated by intraperitoneal injection of Ringer's lactate (50 ml/kg body weight). Thermally injured rats were then randomly divided into one of seven groups (n = 5 each group) to receive, weekly subcutaneous injections of liposomes (10 l liposomes in 180 l saline) containing 0.2, 2.2, or 22.2 g of KGF or IGF-I cDNA construct. The control group received liposomes containing 0.2 g of the reporter gene for ␤-galactosidase LacZ cDNA construct (vehicle). In the present study, the liposome to DNA and the beta-gal to KGF or IGF-I cDNA ratios were kept constant, but the concentrations were altered or there would have been problems with DNA falling out of solution.
The rat cDNA for KGF and IGF-I were inserted into plasmid constructs driven by a CMV promoter. All constructs were prepared at the UTMB Sealy Center for Molecular Science Recombinant DNA Core Facility. The liposomes were formulated from 1:1 (M/M) DMRIE (1,2-dimyristyloxypropyl-3-dimethyl-hydroxyl ethyl ammonium bromide) and cholesterol suspended in membrane-filtered water (Life Technologies, Rockville, MD, USA). This reagent interacts spontaneously with the cDNA to form lipid cDNA complexes.
Immediately after the thermal injury, each rat received 0.2 ml of the lipoplexes subcutaneously injected on the back at two sites opposite from each other. This was repeated each week for 4 weeks and mixtures were freshly prepared before each injection. Animals were killed by decapitation 5 days after the last injection. Blood was collected into serum and plasma separators, spun at 1000 g for 15 min, and the supernatant and pellet were separated and stored at Ϫ73 o C. Skin samples from the back were harvested, fixed in formaldehyde, or snap-frozen in liquid nitrogen, and stored at Ϫ73 o C for analysis.
Controls
Previous studies performed and published by our group investigated the injection of the naked protein for growth factors, liposomal encapsulated proteins, LacZ in different doses, empty liposomes. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] They all indicated that liposomes containing the LacZ cDNA for ␤-galactosidase represents the most appropriate controls. Therefore, liposomes were used in the present study which contained 0.2 g LacZ cDNA as a control group.
Transfection
Transfection was determined in skin samples taken 33 days after burn and 5 days after the last injection by measuring the presence of ␤-galactosidase. The presence of the ␤-galactosidase protein in the skin was detected by histochemical staining with Bluo-Gal (halogenated indolyl-␤-d-galactoside) (Life Technologies, Gaithersburg, MD, USA) and has been previously published. 9, 12 KGF skin concentration KGF protein concentrations in the skin were measured by antibodies against KGF using standard immunohistochemical techniques. Paraffin embedded samples were cut 4 m in thickness, placed in an increasing alcohol concentration and finally in PBS. Protease K (100 g/ml) was applied at 37°C for 30 min. After washing with PBS endogen peroxidases were blocked using methanol-H 2 O 2 for 15 min. The samples were then washed again. The primary antibody goat anti-KGF (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was applied to the samples and then incubated at 4°C for 16 h (overnight). After another washing the secondary antibody DAKO E 0466 (biotinylated rabbit anti-goat, 1:400) was incubated for 1 h at 37°C followed by another washing. The samples were then incubated with Streptavidin DAKO P 0397 (1:300) for 1 h at 37°C and again washed. The counterstaining was performed using hematoxylin. After placing the samples in an increasing alcohol row they were embedded in medium.
KGF concentration was determined by the staining intensity. Three observers blinded for treatment scored each sample from 1 to 4, whereby 1 = weak staining, few KGF concentration, 4 = strong staining, high density of KGF in the neo-skin.
IGF-I skin concentration
IGF-I protein concentrations were measured using rat radioimmunoassay (RIA) in skin biopsies taken 33 days after burn. The protocol followed and kit used (Diagnostic System Laboratories, Webster, TX, USA) were published in a previous study.
9,12
Re-epithelization Re-epithelization was determined by planimetry and by histological examinations. Planimetry was performed as follows: the wound eschar was left intact for the first 28 days and then removed by gentle traction, caution being taken not to disturb or destroy the healing edge along the periphery. After removing the eschar, the animals were placed on a standard surface and the wound area was traced on to acetate sheets along the well-demarcated reepithelized, non-burned interface and the leading edge of the neo-epithelium. The areas of these tracings were calculated by computerized planimetry (Sigma Scan and Sigma Plot software, San Rafael, CA, USA). The area of re-epithelization was calculated by the formula shown below. Values are expressed as percent re-epithelization from the original burn wound. Epithelization = (o Ϫ i)/b × 100, where o = outer area 4 or 5 weeks after burn; i = inner area 4 or 5 weeks after burn; b = original area at the time of burn.
Histologically re-epithelization was determined in skin samples taken 33 days after burn and 5 days after the last lipoplex injection. Linear skin biopsies were taken and were approximately 4 mm thick in width and extended from the center of the burn wound into the surrounding normal skin. Skin specimens were fixed overnight at 4°C in 4% paraformaldehyde in a HEPES-buffered Hank's solution at pH 7.6. Skin was then stained for HE. 47 Distance of re-epithelization was determined by measuring the length from the normal, uninjured skin (identified by skin appendix structures, such as hair follicle, glands, etc) till the end of the neo-epithelium covering the wound and granulation tissue. Measurements were repeated twice by observers blinded to the treatment. Length was calculated by forming the average of these two measurements.
Collagen morphology and deposition
Quality and quantity of collagen was determined by the Masson Goldner Trichrome staining. 47 Quality and quantity of collagen was determined by the Masson Goldner Trichrome staining. Qualitative measurements of the wound collagen were performed by examining the pannus for boundless collagen and the staining intensity of collagen in the area at the wound edge. The collagen morphology and staining intensity were determined by three observers blinded to the treatment. A score from 1 to 4 was given to each sample, whereby 1 = boundless collagen is linear, and 4 = boundless collagen which appears to have normal histological structures ('angel curl shape'). Similarly a score from 1 to 4 was given for staining intensity for the collagen pannus, 1 = weak bluegreen staining, few collagen concentration, 4 = strong blue-green staining, high density of collagen in the pannus.
The length of the collagen pannus being deposited in the dermal wound structures was determined by measuring the distance from the normal, uninjured skin till the end of the collagen pannus in the granulation tissue. Measurements were repeated twice by observers blinded to the treatment. Length was calculated by forming the average of the two measurements. Depth of the collagen pannus was determined in the same fashion. The area of the collagen pannus was calculated by multiplying the length times the depth of the pannus.
Skin cell proliferation and apoptosis
Skin cell proliferation was determined using antibodies against KI 67. KI 67 stains cells that have undergone mitosis over the last 24 h. Paraffin sections 3 to 5 m thick were mounted on 'Superfrost Plus' slides, heated for 20 min at 72°C, deparaffinized and rehydrated. Sections were placed in a microwave for 30 min at 240 W in a citrate buffer at pH = 7.3, then cooled to room temperature. Following antigen retrieval, the slides were rinsed, endogenous peroxidase activity was blocked by using methanolic peroxide, the slides were rinsed again, and primary monoclonal antibody against Ki-67 (BD PharMingen, USA; Cat No. 36521A) in a dilution of 1:100 was applied. All slides were stained using a Ventana machine and each antibody incubation was performed at 37°C and labeled streptavidin-biotin-peroxidase method at 37°C was used to visualize positive reaction (Ventana Medical Systems basic DAB detection kit, Ventana Medical Systems Inc, USA). A dark brown nuclear precipitate was evaluated as a positive reaction. Tonsils were used for positive control and sections incubated without primary antibody did not yield positive immunoreactivity.
All skin cells in the pannus and along the basal layer were counted. Proliferation was then determined by positive stained skin cells per 100 counted skin cells. Three observers blinded to the treatment groups were recruited to count the cells.
Apoptosis was measured using the TUNEL (terminal deoxyuridine nick end labeling) immunohistochemical method (Apoptag; Oncogene, Baltimore, MD, USA) in order to allow histologic identification of apoptotic cells in the skin. Formalin-fixed tissues were processed and embedded into paraffin. Sections of 4-m, obtained at 40-50 m intervals, were deparaffinized, rehydrated in graded alcohol and washed in deionized water. Protein was digested using proteinase K (20 l/ml in phosphate buffered saline (PBS)) to decrease background contamination. The sections were then incubated with freshly prepared TdT (terminal deoxyribonucleotidyl transferase) enzyme at 37 o C for 2 h. Following the enzyme incubation, the slides were incubated with anti-digoxigGene Therapy enin peroxidase at room temperature for 30 min. The sections were thoroughly washed and diaminobenzidinehydrogen peroxidase was applied for color development. Lastly, the sections were counterstained with Mayer's hematoxylin and mounted.
Two sections (4 m) of each block of tissue were obtained at 40 to 50 m intervals. In each section, three observers blinded to treatment counted TUNEL-positive cells. Apoptotic cells were identified as those with a brown staining of the nucleus, or as apoptotic bodies, which are fragments of apoptotic cells engulfed by neighboring epithelial cells. All epithelial cells within the skin were counted and apoptosis was expressed as a percentage of apoptotic cells per hundred epithelial cells. Values for all sections were averaged to calculate apoptosis for the apoptotic rate in the skin.
Net balance, which determines net cell turnover, was calculated by proliferation divided by apoptosis.
Neo-angiogenesis
Neo-angiogensis, newly formed blood vessels in the granulation tissue, are of major importance for wound healing. The newly formed tissue depends on nutrition and growth factors delivered to the wound, by neo-angiogenesis. Neo-angiogenesis was determined by quantifying blood vessels in the granulation tissue. Three observers, blinded to treatment, counted the blood vessels in three different sections of the granulation tissue using a magnification of ×40 (high power field). Values were averaged and calculated as blood vessels per m 2 .
Ethics and statistics
These studies were reviewed and approved by the Animal Care and Use Committee of the University of Texas Medical Branch, Galveston, TX, USA and Regierung der Oberpfalz, Bayern, Germany assuring that all animal received humane care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health. Statistical comparisons were made by analysis of variance (ANOVA) and Student's t test with the Bonferroni's correction. Data are expressed as means ± standard error of the mean (s.e.m.) or means ± standard deviation, where appropriate. Significance was accepted at P Ͻ 0.05.
